Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder-Reference-Cited by-同舟云学术

Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder

Author:

Haab F.¹,Braticevici B.²,Krivoborodov G.³,Palmas M.⁴,Zufferli Russo M.⁵,Pietra C.⁶

Affiliation:

1. Department of Urology; Hopital Tenon; Paris France

2. Department of Urology I; Spitalul Clinic; Bucharest Romania

3. Department of Urology; Russian National Research Medical University of N.I. Pirogov; Moscow Russia

4. Corporate Clinical Development; Helsinn Healthcare; SA, Lugano Switzerland

5. Corporate Clinical Development, Statistics and Data Management; Helsinn Healthcare; SA, Lugano Switzerland

6. Research and Preclinical Development; Helsinn Healthcare; SA, Lugano Switzerland

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

Reference15 articles.

4. Newer agents for the management of overactive bladder;Epstein;Am Fam Physician,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

;Clinical Epidemiology;2019-02